Other Metabolic

Significant Weight Loss: Clinical trials (REDEFINE 1) demonstrated that 2.4-mg doses of cagrilintide resulted in a 11.8% reduction in body weight compared to 2.3% for a placebo. Enhanced Appetite Suppression: By mimicking the hormone amylin, it increases satiety and reduces cravings, leading to lower caloric intake. Improved Glycemic Control: It helps manage blood sugar levels,…